Clinical Trial

Registry to Collect Information on Pregnancy, Neonatal, and Infant Outcomes in Pregnant Women Exposed to QUVIVIQ®

Recruiting
View on ClinicalTrials.gov →
Summary
This study will investigate pregnancy, neonatal, and infant outcomes in women exposed to QUVIVIQ during pregnancy compared to women unexposed to QUVIVIQ during pregnancy.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-07-05; most recent amendment 2025-12-01.
Status change: Not Yet Recruiting → Recruiting 2024-12-13
Trial Details
NCT Number NCT06498128
Lead Sponsor Idorsia Pharmaceuticals Ltd.
Collaborators: IQVIA Pty Ltd
Conditions Insomnia
Enrollment 785 participants
Start Date 2024-11-21
Primary Completion 2033-03 (estimated)
Study Completion 2033-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-02